# Stage E-PS — shard 3 of 4 — 2026-10-27

This is stage E-PS, shard 3 of four. It runs beside stage E-P with Opus 5.5 searchers and a blind four-model panel, on E-P's own names, sweep and sealed baselines (source commit a0955166). It places no orders. One day is an anecdote.

- **Names:** KIDS, UCTT, FSP (all amc 2026-10-27); REPL, AMRN (both bmo 2026-10-28).
- **Searchers:** five `unpriced-searcher` agents, launched in one message. All 5 returned. None reported that its search budget ran out.
- **Guard:** `intraday.py guard` moved nothing.
- **Judges:** all four ran, each as its pinned agent: opus5 (claude-opus-5), opus55 (claude-opus-5-5), sonnet55 (claude-sonnet-5-5) and fable51 (claude-fable-5-1). Coverage was 5 of 5 for each judge. Scored with `--dry-run --stage E-PS`, so the panel history was not written.
- **Claim to done:** claimed at 17:23 UTC; panel scored at 17:47 UTC.
- **Searcher key:** the searcher's own `impact_sum` was UCTT +2.70, KIDS +2.50, REPL +0.10, FSP −0.30 and AMRN −3.40. AMRN is the only name above the 2.8 floor.

## Panel (as printed by panel_score.py)

```
members opus5, opus55, sonnet55, fable51; selection panel_pct >= 80, all 4 members present; 0 sizes added to the history
own top 20% starts at: opus5 |1.80|, opus55 |1.19|, sonnet55 |1.15|, fable51 |1.44|  (live sizes before 2026-10-27, opus5 n=196 live, opus55 n=196 live, sonnet55 n=196 live, fable51 n=196 live)
rank ticker   session sel pct side    sd  members (own percentile, L/S)                 k  score  E[return] at this pct (80% band)  P(right)
   1 AMRN     bmo     yes  97 short    2  opus5: 94S* opus55: 97S* sonnet55: 99S* fable51: 96S*  4  -2.26  +4.87% [+2.95, +6.58]           0.72
   2 KIDS     amc     yes  94 long     4  opus5: 99L* opus55: 96L* sonnet55: 89L* fable51: 91L*  4  +1.84  +4.59% [+2.58, +6.39]           0.71
   3 UCTT     amc          78 long     9  opus5: 67L  opus55: 73L  sonnet55: 91L* fable51: 83L*  2  +1.09  +2.43% [+0.55, +4.33]           0.59
   4 FSP      amc          59 short    8  opus5: 67S  opus55: 66S  sonnet55: 47S  fable51: 58S   0  -0.78  +0.77% [-0.14, +2.23]           0.56
   5 REPL     bmo           5 short   45  opus5: 58S  opus55: 35S  sonnet55: 57L  fable51: 17L   0  -0.03  +0.29% [-0.73, +0.78]           0.56
E[return]: what a name at this panel_pct has earned on the panel's side (one number per percentile, scorebord window, gross); curve fitted 2026-10-14T08:30:16+00:00 on 148 resolved panel names.
```

**Selected names: AMRN (short) and KIDS (long).** All four judges put each of them in their own top 20%.

- **AMRN:** the searcher found CVS Caremark's formulary documents, dated "current as of October 1, 2026", which drop VASCEPA from 2027. No 8-K and no news coverage mentions this. The case against: management may not disclose it on the call, and net cash of about $15 per ADS sits under a $12 stock.
- **KIDS:** Q3 consensus is set below Q2, yet Q3 has matched or beaten Q2 for three years. The stock has rallied on every 2026 beat. The case against: the seasonality argument is an inference, and the baseline's reaction history mixes in pre-announcement dates (`cadence_implausible`).
- **REPL:** the judges split by side (spread 45).
- **UCTT:** two of four judges put it in their top 20%, which does not meet the mean rule.

`E[return]` is what names at that percentile have earned before. It is gross, on the scorebord window, and has a weak out-of-sample record. It is not a forecast to size on.

This is research, not financial advice. Earnings reactions are highly uncertain and can be driven by market positioning, guidance, macro conditions, and management commentary rather than reported results alone.
